About Active Pharmaceutical Ingredients
Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology, respiratory disorders, and rheumatoid arthritis.
TechNavio's analysts forecast the API market in India to grow at a CAGR of 10.76 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the API market in India during the period 2014-2019. To calculate the market size, the report considers the revenue generated from the sales of API by vendors in the market. The report provides the vendor landscape and a corresponding detailed analysis of the top three vendors in the market. The market segmentation data and analysis is also provided for the following segmentation types: type of production process and area of therapy.
In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.
TechNavio's report, the API Market in India 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.
Key Vendors
• Aurobindo Pharma
• Cipla
• Dr. Reddy's Laboratories
Other Prominent Vendors
• Anuh Pharma
• Alembic Pharmaceuticals
• A. R. Life Sciences
• Atul Bioscience
• Biocon
• Cadila Pharmaceuticals
• Calyx Chemicals & Pharmaceuticals
• CIRON Drugs and Pharmaceuticals
• CTX Life Sciences
• Dishman Pharmaceuticals & Chemicals
• Elder Pharmaceuticals
• Emcure Pharmaceuticals
• FDC
• Glenmark Pharmaceuticals
• Hetero Drugs
• Hikal
• Ind-Swift Laboratories
• Ipca Laboratories
• J. B. Chemicals and Pharmaceuticals
• Laurus Labs
• Lupin
• Mangalam Drugs & Organics
• Mylan Laboratories
• Orchid Chemicals and Pharmaceuticals
• Ranbaxy Laboratories
• Sandoz
• Sequent Scientific
• Shasun Pharmaceuticals
• Sterling Biotech
• Sun Pharmaceutical Industries
• The Piramal Group
• Torrent Pharmaceuticals
• Unichem Laboratories
• Wockhardt
Market Driver
• Strong Preference for Generic Drugs
• For a full, detailed list, view our report
Market Challenge
• Regulatory Ban
• For a full, detailed list, view our report
Market Trend
• Emergence of Africa
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
07. API Market in India
07.1 Market Size and Forecast
07.2 Export and Domestic Consumption
07.3 Five Forces Analysis
08. Market Segmentation by Type of Production Process
09. Market Segmentation by Area of Therapy
09.1 API Market in India for Anti-infectives
09.1.1 Market Segmentation by Type
09.2 API Market in India for the Cardiovascular and Hematopoietic System
09.2.1 Market Segmentation by Type
09.3 API Market in India for the Central Nervous System
09.3.1 Market Segmentation by Type
09.4 API Market in India for the Gastro-intestinal and Hepatobiliary System
09.4.1 Market Segmentation by Type
09.5 API Market in India for the Respiratory System
09.5.1 Market Segmentation by Type
09.6 API Market in India for Oncology
09.6.1 Market Segmentation by Type
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.2 Key Vendor Ranking 2014
17.3 Other Prominent Vendors
18. Key Vendor Analysis
18.1 Aurobindo Pharma
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Business Segmentation
18.1.4 Geographical Segmentation by Revenue 2014
18.1.5 Business Strategy
18.1.6 Recent Developments
18.1.7 SWOT Analysis
18.2 Cipla
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Product Segmentation
18.2.4 Geographical Segmentation by Revenue 2014
18.2.5 Business Strategy
18.2.6 Recent Developments
18.2.7 SWOT Analysis
18.3 Dr. Reddy's Laboratories
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation by Revenue 2014
18.3.4 Business Segmentation by Revenue 2013 and 2014
18.3.5 Geographical Segmentation by Revenue 2014
18.3.6 Business Strategy
18.3.7 Recent Developments
18.3.8 SWOT Analysis
19. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: API Market in India: Segmentation
Exhibit 3: API Market in India: Segmentation by Type of Production Process
Exhibit 4: API Market in India: Segmentation by Area of Therapy
Exhibit 6: API Market in India 2014-2019 (US$ billion)
Exhibit 7: API Market in India: Export and Domestic Consumption 2014
Exhibit 8: API Market in India: Market Segmentation by Type of Production Process 2014
Exhibit 9: API Market in India: Segmentation by Area of Therapy 2014
Exhibit 10: API Market in India for Anti-infectives: Segmentation by Type 2014
Exhibit 11: API Market in India for the Cardiovascular and Hematopoietic System: Segmentation by Type 2014
Exhibit 12: API Market in India for the Central Nervous System: Segmentation by Type 2014
Exhibit 13: API Market in India for the Gastro-intestinal and Hepatobiliary System: Segmentation by Type 2014
Exhibit 14: API Market in India for the Respiratory System: Segmentation by Type 2014
Exhibit 15: API Market in India for Oncology: Segmentation by Type 2014
Exhibit 16: Small Molecule Drugs: Patent Expiries 2013-2016
Exhibit 17: WHO's List of Prequalified API for Vendors in India (22nd October, 2014)
Exhibit 18: Biologic Drugs: Patent Expiries 2014-2019 (EU and US)
Exhibit 19: API Market in India: Segmentation by Type of Vendors 2014
Exhibit 20: Aurobindo Pharma: Business Segmentation
Exhibit 21: Aurobindo Pharma: Geographical Segmentation by Revenue 2014
Exhibit 22: Cipla: Product Segmentation
Exhibit 23: Cipla: Geographical Segmentation by Revenue 2014
Exhibit 24: Active Pharmaceutical Ingredients (API) Market in India: Business Segmentation by Revenue 2014
Exhibit 25: Active Pharmaceutical Ingredients (API) Market in India: Business Segmentation by Revenue 2013 and 2014 (US$ billion)
Exhibit 26: Dr. Reddy's Laboratories: Geographical Segmentation by Revenue 2014
